Biohaven announces $250M common share offering

Biohaven announced that it has commenced an underwritten public offering of $250M of its common shares. All of the common shares to be sold in the offering will be offered by Biohaven. Biohaven intends to use the net proceeds received from the offering for general corporate purposes. J.P. Morgan and Morgan Stanley are acting as book-running managers of the offering.